Construction and Application of Precise Diagnosis and Treatment System for Thyroid-associated Ophthalmopathy

Recruiting now

Conditions studied: Thyroid Associated Ophthalmopathy

In brief

This study aims to develop the deep learning-based system that integrates multimodal information to automatically diagnose, stage, and grade thyroid-associated ophthalmopathy (TAO), assist in treatment decision-making, and predict patient prognosis, thereby providing novel tools to support clinical management.

Key facts

Study ID

NCT07124572

Run by

Second Affiliated Hospital, Zhejiang University, School of Medicine

People needed

500

Starts

2022-10-01

Expected to finish

2031-10-01

Last updated by the study team

2025-08-15

Who can join

Age: 7 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• normal participants without eyelid disorders (control group)
• patients with thyroid-associated ophthalmopathy (TAO group)
• cooperative participants

You may not qualify if…

• participants with pupil or cornea disorders
• participants with history of eye injury

Where it is running

• Juan Ye — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.